Milnacipran Impurity 14 | CAS 810696-16-3 - Request Quote
Milnacipran Impurity 14
| SZ CAT No: | SZ-M040021 |
| CAS No | 810696-16-3 |
| Mol.F. | C11H11NO |
| Mol.Wt. | 173.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Milnacipran Impurity 14 is chemically (1S,5R)-1-Phenyl-3-azabicyclo[3.1.0]hexan-2-one. Milnacipran Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Milnacipran Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Milnacipran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 810696-16-3
Purchase 810696-16-3
Order 810696-16-3
Enquire 810696-16-3
price of 810696-16-3
810696-16-3 Supplier
810696-16-3 Manufacturer
810696-16-3 Exporter
buy high quality Milnacipran Impurity 14
Purchase Milnacipran Impurity 14
Milnacipran Impurity 14 suppliers
Milnacipran Impurity 14 manufacturers
Milnacipran Impurity 14 price
Order Milnacipran Impurity 14
Enquire Milnacipran Impurity 14
Milnacipran Impurity 14 cost
Milnacipran Impurity 14 Supplier
Milnacipran Impurity 14 Distributor
Milnacipran Impurity 14 for Method Validation
Milnacipran Reference Standard
Milnacipran Impurity 14 for ANDA Filing
Milnacipran Impurity 14 for Forced Degradation Studies
Milnacipran Impurity 14 Identification Standards
Milnacipran Impurity 14 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


